MICHELSON
PRIZES

2018 Winners

The Michelson Medical Research Foundation together with the Human Vaccines Project are pleased to present the inaugural Michelson Prize winners:

  • Patricia Therese Illing, PhD
    Monash University

    Spliced peptides: Novel candidates for effective influenza immunity?


    Watch Video
  • Ansuman Satpathy, MD, PhD
    Stanford University School of Medicine

    Epigenomic mechanisms of vaccine-induced immunity


    Watch Video
  • Laura Mackay, PhD
    The Peter Doherty Institute for Infection and Immunity

    Targeting tissue-resident immune cells for enhanced immune protection


    Watch Video

June 22, 2018

Gala Highlights

Load More
About the Prizes Eligibility And Application
×
Patricia Therese Illing, PhD
Fellow
Monash University
Spliced peptides: Novel candidates for effective influenza immunity?

Dr. Illing was the first to identify spliced peptides during a viral infection. This work involves an innovative new approach for identifying influenza-specific peptide antigens with implications for the development of vaccines against both seasonal and pandemic influenza strains. The Prize money will provide greater resources to expand understanding of how a viral antigen is recognized by the human immune system.

More on Patricia Therese Illing, PhD's work
Ansuman Satpathy, MD, PhD
Instructor
Stanford University School of Medicine
Epigenomic mechanisms of vaccine-induced immunity

Dr. Satpathy is focused on combining disciplines of genomics and human immunology. His research will identify key gene regulatory mechanisms that trigger protective immunity following vaccination using novel epigenomic sequencing technologies applied directly to patient samples. The Prize will allow him to greatly accelerate his work, advancing both 3D and single-cell epigenetic technologies to human immunology and vaccine research.

More on Ansuman Satpathy, MD, PhD's work
Laura Mackay, PhD
Laboratory Head and Senior Lecturer
The Peter Doherty Institute for Infection and Immunity
Targeting tissue-resident immune cells for enhanced immune protection

Dr. MacKay is studying recently described subset of immune cells called tissue resident memory T cells, which combat various viral infections and cancer. The research that will be funded by the Prize will examine immune responses by tissue resident memory T cells to harness their protective functions to improve vaccines and immunotherapies.

More on Laura Mackay, PhD's work
×

Patricia Therese Illing, PhD
Monash University

Spliced peptides: Novel candidates for effective influenza immunity?

Ansuman Satpathy, MD, PhD
Stanford University School of Medicine

Epigenomic mechanisms of vaccine-induced immunity

Laura Mackay, PhD
The Peter Doherty Institute for Infection and Immunity

Targeting tissue-resident immune cells for enhanced immune protection
×






Dr. Patricia Therese Illing, Research Fellow, Monash University (2018 Michelson Prize Winner)




Gala Dinner – Bashor Lounge – University of Southern California




Gala Dinner – Bashor Lounge – University of Southern California




Wayne C Koff, PhD, President & CEO, Human Vaccines Project and Laura Mackay, Senior Lecturer, The Peter Doherty Institute of Infection and Immunity, University of Melbourne (2018 Michelson Prize Winner)







Ian David Gust, AO, MD, Professorial Fellow, University of Melbourne (Human Vaccines Project Board Chair) & Dr. Patricia Therese Illing, Research Fellow, Monash University (2018 Michelson Prize Winner)




Stanley A Plotkin, MD, Consultant in Vaccinology, Professor Emeritus of Pediatrics, University of Pennsylvania, Professor Emeritus, Wistar Institute, Philadelphia, Adjunct Professor, Johns Hopkins University, Baltimore (Human Vaccines Project, Board Chair Emeritus)




Marie-Paule Kieny, PhD,  Research Director, International Institutional Relationships, Inserm   (Human Vaccines Project Board Member)




Wayne C Koff, PhD, President & CEO, Human Vaccines Project and Ian David Gust, AO, MD, Professorial Fellow, University of Melbourne (Human Vaccines Project Board Chair)




Dr. Gary K Michelson, Philanthropist




Dr. Patricia Therese Illing, Research Fellow, Monash University (2018 Michelson Prize Winner)




Stanley A Plotkin, MD, Consultant in Vaccinology, Professor Emeritus of Pediatrics, University of Pennsylvania, Professor Emeritus, Wistar Institute, Philadelphia, Adjunct Professor, Johns Hopkins University, Baltimore (Human Vaccines Project, Board Chair Emeritus)




Wayne C Koff, PhD, President & CEO, Human Vaccines Project and Laura Mackay, Senior Lecturer, The Peter Doherty Institute of Infection and Immunity, University of Melbourne (2018 Michelson Prize Winner)




Wayne C Koff, PhD, President & CEO, Human Vaccines Project




Laurie Garrett, Author, Lecturer, Policy (Pulitzer Prize Winning Journalist)







Margret Hamburg, Former Commissioner of the US FDA and currently Foreign Secretary for the National Academy of Medicine and President of the American Academy for the Advancement of Science (AAAS)







Mark M Davis, PhD, Director, Institute for Immunity, Transplantation & Infection, The Burt & Marion Avery Family Professor of Immunology, Investigator, Howard Hughes Medical Institute, Stanford University, School of Medicine & Ansuman Satpathy, Instructor, Stanford University (2018 Michelson Prize Winner)




Dr. Steve Kay, Director of the MESH (Medicine, Engineering, Sciences, and Humanities) Academy, Director, USC Michelson Center for Convergent Bioscience & Provost Professor of Neurology, Biomedical Engineering & Biological Sciences at the Keck School of Medicine of USC




Wayne C Koff, PhD, President & CEO, Human Vaccines Project & Ansuman Satpathy, Instructor, Stanford University (2018 Michelson Prize Winner)

Subscribe to our Newsletter